CLARK, N.J. — The Chronic Liver Disease Foundation announced Tuesday that it's collaborating with Walgreens to offer free Hepatitis C (HCV) testing with the OraQuick HCV Rapid Test at more than 60 Walgreens retail pharmacies in 12 major cities throughout the country.
The program, which is slated to launch this August and run through January 2016, will offer free rapid HCV testing on specific days and times each week to patients at risk for HCV. Rapid testing and patient education will be conducted by trained healthcare professionals on site at each retail location and individuals who test positive will be linked directly to one of CLDF's 75 Hepatology Centers of Expertise throughout the United States.
"The rapid hepatitis testing program demonstrates our commitment to helping patients access important information that can help to improve their health," said Glen Pietrandoni, senior director, virology, Walgreens. "We are proud to collaborate with the Chronic Liver Disease Foundation on this initiative. Through this testing program we can help people become educated on the risk factors, identify people infected with HCV and help them get linked to appropriate care."
"Today, approximately 5.2 million Americans have hepatitis C and the vast majority does not know it," said Willis Maddrey, president of the Chronic Liver Disease Foundation. "However, new therapies are now available that can effectively treat and cure hepatitis C.
Each year, about 17,000 Americans become infected with Hepatitis C. Up to 75% of people with chronic Hepatitis C infection were born during 1945-1965, and up to three out of four people infected with Hepatitis C are unaware of their infection.
OraQuick HCV is the first and only FDA-approved and CLIA-waived point of care test for detection of HCV infection in at-risk individuals. The platform allows healthcare providers to deliver an accurate diagnosis in 20 minutes, using venipuncture or fingerstick blood. The test is manufactured by OraSure Technologies in Bethlehem, Pa.